| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |